Access 2.8M+ Filings Sign Up Free
Orexo Logo

Orexo | ORX - Profile, Filings, Stock Info & Investor Relations Data

Orexo | ORX
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Pharmaceuticals
Country
Sweden
Founded
1995
Orexo (ORX)

Company Profile

Website
Investor Relations

About Orexo

Orexo develops improved pharmaceuticals and digital therapies addressing unmet needs within the growing space of mental illness and substance use disorders. The products are commercialized by Orexo in the US or via partners worldwide. The main market today is the American market for buprenorphine/naloxone products, where Orexo commercializes its lead product ZUBSOLV® for the treatment of opioid use disorder.

- Developed four commercial pharmaceutical products with worldwide approval
- Addresses unmet need within the growing space of mental illness and addiction disorders
- Broad product portfolio and development pipeline of traditional pharma products and digital therapies
- Strategic focus on portfolio expansion through development, licensing and M&A
- Strong cash generation from the business area US Pharma enabling to invest in future growth

Market Presence

Worldwide

Headquarters

Box 303
751 05, UPPSALA
Sweden

Company Video

Video thumbnail
Click to load video from YouTube

Orexo (ORX)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Orexo (ORX)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

↑
Nikolaj Arrild Sørensen (Other)
Buy SEK 35,178.00 SEK 14.30 11.04.25
↑
Nikolaj Arrild Sørensen (Other)
Buy SEK 47,530.00 SEK 13.58 04.04.25
↑
Fredrik Järrsten (Other)
Buy SEK 44,040.00 SEK 14.68 26.03.24
↑
Charlotte Vithlani Hansson (Other)
Buy SEK 44,640.00 SEK 14.88 24.11.23
↑
Fredrik Järrsten (Other)
Buy SEK 23,715.00 SEK 15.81 08.11.23
↑
Nikolaj Arrild Sørensen (Other)
Buy SEK 188,945.00 SEK 16.43 24.02.23
↑
Fredrik Järrsten (Other)
Buy SEK 79,695.00 SEK 17.71 27.01.23
↑
Michael Matly (Other)
Buy SEK 60,777.77 SEK 21.55 26.07.22
↑
Charlotte Vithlani Hansson (Other)
Buy SEK 61,500.00 SEK 20.50 21.07.22
↑
James Noble (Other)
Buy SEK 394,252.80 SEK 21.31 15.07.22

Orexo (ORX)
Stock & Investor Information

ISINs

SE0000736415
SE0007305982
SE0021515277

LEI

549300LJ5CCWDPTK9Z08

Stock Exchange Listings

Nasdaq Stockholm

Industry Classification

Sector
Health Care
Industry
Pharmaceuticals